Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
By AI Tool Hub Analyst
Share
"The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s."
